Gilead Sciences Ownership | Who Owns Gilead Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Gilead Sciences Ownership Summary


Gilead Sciences is owned by 86.10% institutional investors, 0.10% insiders, and 13.80% retail investors. Blackrock is the largest institutional shareholder, holding 9.67% of GILD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.17% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGilead Sciences86.10%0.10%13.80%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryDrug Manufacturers - General Stocks50.22%2.50%47.29%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock120.63M9.67%$8.28B
Vanguard group115.53M9.26%$10.67B
Blackrock funding, inc. /de114.88M9.23%$12.74B
State street59.33M4.76%$4.07B
Capital world investors46.30M3.72%$5.13B
Fmr40.32M3.23%$3.72B
Wellington management group llp35.66M2.86%$3.29B
Capital research global investors31.10M2.50%$3.45B
Dodge & cox30.82M2.48%$3.42B
Geode capital management28.29M2.27%$2.61B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sofinnova investments1.05M7.12%$116.45M
Mccarthy asset management130.36K5.27%$8.94M
Sector gamma as127.00K4.60%$14.08M
Twin lakes capital management60.33K4.07%$6.69M
Natwest group123.47K4.05%$13.69M
One river asset management14.24K3.48%$1.58B
Healthinvest partners ab73.17K3.47%$8.11M
Globeflex capital l p377.55K3.47%$41.86M
Verity & verity378.10K3.19%$34.93M
Kiltearn partners llp134.40K3.00%$14.90M

Top Buyers

HolderShares% AssetsChange
Norges bank19.37M0.23%19.37M
Fmr40.32M0.22%7.16M
Pacer advisors6.43M1.28%5.65M
Bank of new york mellon16.76M0.30%2.83M
Qube research4.76M0.54%2.40M

Top Sellers

HolderShares% AssetsChange
Capital research global investors31.10M0.69%-23.51M
Capital world investors46.30M0.75%-7.24M
Citadel advisors278.39K0.00%-5.04M
Legal & general group9.91M0.24%-2.29M
Two sigma advisers, lp270.80K0.06%-2.22M

New Positions

HolderShares% AssetsChangeValue
Norges bank19.37M0.23%19.37M$1.79B
Worldquant millennium advisors777.25K0.43%777.25K$86.17M
Masters capital management385.00K1.49%385.00K$26.41M
Fjarde ap-fonden (the fourth swedish national pensionfund)296.46K0.23%296.46K$20.34M
Ofi invest asset management281.62K0.59%281.62K$25.12M

Sold Out

HolderChange
Hoey investments-2.00
Country trust bank-3.00
Mendota financial group-3.00
Kohmann bosshard financial services-4.00
Cypress capital management llc (wy)-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252,053-0.73%1,072,004,9014.47%861.27%1,0044.26%720-12.41%
Mar 31, 202519-99.01%5,280,450-99.50%-0.01%7-99.24%5-99.30%
Dec 31, 20241,238-29.82%522,772,791-49.04%410.62%590-25.69%468-31.68%
Sep 30, 20241,7401.05%1,025,105,383-1.03%821.19%7841.69%673-0.30%
Jun 30, 20241,691-3.92%1,032,995,9351.04%821.23%7591.61%663-9.80%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF39.45M3.17%28.77K
Vanguard Total Stock Mkt Idx Inv39.10M3.15%-901.45K
Vanguard Institutional 500 Index Trust35.44M2.85%245.78K
Vanguard 500 Index Investor30.79M2.48%-4.51M
Invesco QQQ Trust25.52M2.05%-15.99K
Dodge & Cox Stock I22.94M1.84%-1.41M
American Funds Income Fund of Amer A19.87M1.60%-4.12M
Fidelity 500 Index15.76M1.27%37.96K
SPDR® S&P 500 ETF15.51M1.25%-227.69K
SPDR® S&P 500® ETF15.08M1.21%-62.87K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 28, 2025O'Day Daniel Patrick Chairman & CEOSell$1.14M
Aug 15, 2025Mercier Johanna Chief Commercial OfficerSell$1.40M
Aug 15, 2025Mercier Johanna Chief Commercial OfficerSell$83.28K
Aug 15, 2025Mercier Johanna Chief Commercial OfficerSell$1.40M
Aug 15, 2025Mercier Johanna Chief Commercial OfficerSell$331.82K

Insider Transactions Trends


DateBuySell
2025 Q3-12
2025 Q2-11
2025 Q1-7
2024 Q4-13
2024 Q3-6

GILD Ownership FAQ


Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 86.10%, followed by 0.10% insiders and 13.80% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 50.22%, which Gilead Sciences exceeds.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Blackrock (120.63M shares, 9.67%), Vanguard group (115.53M shares, 9.26%), and Blackrock funding, inc. /de (114.88M shares, 9.23%). Together, they hold 28.17% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Sofinnova investments is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 7.12% of its assets in 1.05M Gilead Sciences shares, valued at 116.45M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Gilead Sciences shares, with 3.17% of its total shares outstanding invested in 39.45M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools